Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New FTase inhibitors for cancer and other conditions claimed by Servier

Sep. 13, 2002

Avastin fails to meet primary endpoint in phase III metastatic breast cancer trial

Sep. 13, 2002

Cytotoxicity of CHS-828 enhanced in PARP-1-deficient mouse fibroblasts

Sep. 13, 2002

Pro-Pharmaceuticals to advance Davanat-1 into clinic in fourth quarter

Sep. 13, 2002

Antiproliferative effects of selenomethionine in human prostate cancer cells

Sep. 13, 2002

Leo reports cyclic phosphonamide MMP inhibitors with antitumor activity

Sep. 12, 2002

NV-1020 completes phase I in colorectal cancer metastatic to the liver

Sep. 12, 2002

Genta evaluates Genasense in children with solid tumors

Sep. 10, 2002

Novel antitumor compounds isolated from Clavularia corals

Sep. 9, 2002

Novel inhibitors of VEGF expression covered by Mercian patent

Sep. 9, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.